Literature DB >> 3026932

Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy.

I A Eyre-Brook, S Dundas.   

Abstract

Evidence of cytomegalovirus infection has been sought in a consecutive series of patients requiring colonic resection for idiopathic inflammatory bowel disease confined to the colon. Colonic tissue was examined by light and electron microscopy for cytomegalovirus inclusion bodies and cytomegalovirus antigen was sought using an immunoperoxidase technique. Cytomegalovirus infection was identified in three of 26 patients studied, but the infection did not appear to influence the course of the colitis. Although all three patients with cytomegalovirus infection needed urgent surgery, none had toxic megacolon. No evidence of cytomegalovirus infection was found in three other patients with toxic megacolon. One patient, who had a rising titre of IgG to cytomegalovirus received treatment with acyclovir which eradicated cytomegalovirus from the colon without altering the course of the colitis.

Entities:  

Mesh:

Year:  1986        PMID: 3026932      PMCID: PMC1433966          DOI: 10.1136/gut.27.12.1419

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

Review 1.  Inflammatory bowel disease: the surgical pathology of Crohn's disease and ulcerative colitis.

Authors:  A B Price; B C Morson
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

2.  CYTOMEGALIC INCLUSION DISEASE IN THE GASTRO-INTESTINAL TRACT OF ADULTS.

Authors:  R S LEVINE; N E WARNER; C F JOHNSON
Journal:  Ann Surg       Date:  1964-01       Impact factor: 12.969

3.  Cytomegalovirus infection of the colon associated with ulcerative colitis.

Authors:  S Sidi; J H Graham; S A Razvi; P A Banks
Journal:  Arch Surg       Date:  1979-07

4.  Cytomegalovirus colitis. Report of the clinical, endoscopic, and pathologic findings in two patients with the acquired immune deficiency syndrome.

Authors:  M S Meiselman; J P Cello; W Margaretten
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

5.  Viral investigations in ulcerative colitis and regional enteritis.

Authors:  G W Farmer; M M Vincent; D A Fuccillo; L Horta-Barbosa; S Ritman; J L Sever; G L Gitnick
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

6.  Acute ulcerative colitis associated with cytomegalic inclusion virus.

Authors:  H Tamura
Journal:  Arch Pathol       Date:  1973-09

7.  Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease.

Authors:  E T Swarbrick; J G Kingham; H L Price; A J Blackshaw; P D Griffiths; S Darougar; N A Buckell
Journal:  Lancet       Date:  1979-07-07       Impact factor: 79.321

8.  An ultrastructural investigation of cytomegalovirus replication in murine hepatocytes.

Authors:  J M Papadimitriou; G R Shellam; T A Robertson
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

9.  Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection.

Authors:  H S Cooper; E C Raffensperger; L Jonas; W T Fitts
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

10.  Colon ulceration in lethal cytomegalovirus infection.

Authors:  E Foucar; K Mukai; K Foucar; D E Sutherland; C T Van Buren
Journal:  Am J Clin Pathol       Date:  1981-12       Impact factor: 2.493

View more
  22 in total

1.  Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital.

Authors:  Raed Al-Zafiri; Adrian Gologan; Polymnia Galiatsatos; Andrew Szilagyi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

3.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

4.  Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.

Authors:  Toshihiro Inokuchi; Jun Kato; Sakiko Hiraoka; Hideyuki Suzuki; Asuka Nakarai; Tomoko Hirakawa; Mitsuhiro Akita; Sakuma Takahashi; Keita Harada; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 5.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis.

Authors:  Damian Casadesus; Tatsuo Tani; Toshifumi Wakai; Satoshi Maruyama; Tsuneo Iiai; Haruhiko Okamoto; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

Review 7.  Cytomegalovirus infection in the gastrointestinal tract.

Authors:  R Chetty; D E Roskell
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

8.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

10.  Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease.

Authors:  Akifumi Kuwabara; Haruhiko Okamoto; Takeyasu Suda; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.